Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ENCELTO™ safely and effectively. See full prescribing information for ENCELTO. ENCELTO (revakinagene taroretcel-lwey) implant, for intravitreal useInitial U.S. Approval: 2025
Medication labelWhy this: Advisory · dailymed-prescription
ENCELTO is indicated for the treatment of adults with idiopathic macular telangiectasia type 2 (MacTel).
- generic_name
- revakinagene taroretcel-lwey
- product_names
- revakinagene taroretcel-lwey
- ndc
- 82958-501, 82958-501-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en